Doctor profile · Federal record
Dr. Molly Gallogly, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Cleveland, OH
- NPI 1750677613
- Accepts Medicare
- MIPS 79.5 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11100 Euclid Ave
Cleveland, OH 441061716
(216) 864-1000
Credentials & registration
- NPI registered
- June 2011 — 15 yrs on file
- Profile last updated
- January 14, 2021
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Ohio #35.130915
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750677613. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
294
Distinct HCPCS
5
Medicare allowed
$37,624
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 91 | 34 | $139 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 89 | 44 | $138 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 84 | 17 | $117 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 18 | 11 | $95 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 12 | 12 | $95 |
In context: peer comparison
Among 40 peers in Cleveland Hematology & Oncology Physician, average services per provider: 71. This provider delivers 4.1× the peer median.Open Payments
Industry payments received
All-time total
$16,198
Transactions
22
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 11 | $10,413.47 | |
| Incyte Corporation | 9 | $5,635.24 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $99.91 | |
| Genzyme Corporation | 1 | $49.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
602
Patients
51
Total drug cost
$2,164,640
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 182 | 39 | $3,738 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 58 | 0 | $373 |
| Allopurinol | Generic | 37 | 12 | $350 |
| Eliquis (Apixaban) | Brand | 37 | 0 | $26,403 |
| Ninlaro (Ixazomib Citrate) | Brand | 37 | 0 | $479,541 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 36 | 0 | $522,690 |
| Imbruvica (Ibrutinib) | Brand | 32 | 0 | $449,100 |
| Lenalidomide | Generic | 30 | 0 | $405,682 |
| Brukinsa (Zanubrutinib) | Brand | 29 | 0 | $270,834 |
| Gabapentin | Generic | 26 | 0 | $1,011 |
Frequently asked questions
What is Dr. Molly Gallogly's medical specialty?
Dr. Molly Gallogly practices Hematology & Oncology Physician in Cleveland, OH.
Where does Dr. Molly Gallogly practice?
Dr. Molly Gallogly practices at 11100 Euclid Ave, Cleveland, OH 441061716. Office phone: 2168641000.
What is Dr. Molly Gallogly's NPI?
Dr. Molly Gallogly's National Provider Identifier (NPI) is 1750677613, issued by NPPES.
Does Dr. Molly Gallogly accept Medicare assignment?
Yes. Dr. Molly Gallogly accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Molly Gallogly commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99215); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233). Source: CMS Medicare Physician & Other Practitioners file.